Attached files

file filename
10-K - 10-K - SPECTRUM PHARMACEUTICALS INCa55483e10vk.htm
EX-21 - EX-21 - SPECTRUM PHARMACEUTICALS INCa55483exv21.htm
EX-31.2 - EX-31.2 - SPECTRUM PHARMACEUTICALS INCa55483exv31w2.htm
EX-32.1 - EX-32.1 - SPECTRUM PHARMACEUTICALS INCa55483exv32w1.htm
EX-23.2 - EX-23.2 - SPECTRUM PHARMACEUTICALS INCa55483exv23w2.htm
EX-31.1 - EX-31.1 - SPECTRUM PHARMACEUTICALS INCa55483exv31w1.htm
EX-23.1 - EX-23.1 - SPECTRUM PHARMACEUTICALS INCa55483exv23w1.htm
EX-10.29 - EX-10.29 - SPECTRUM PHARMACEUTICALS INCa55483exv10w29.htm
EX-10.37 - EX-10.37 - SPECTRUM PHARMACEUTICALS INCa55483exv10w37.htm
EX-10.36 - EX-10.36 - SPECTRUM PHARMACEUTICALS INCa55483exv10w36.htm
EXHIBIT 32.2
 
CERTIFICATION
 
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Spectrum Pharmaceuticals, Inc. (the “Company”), hereby certifies, to such officer’s knowledge, that:
 
(i) the accompanying Annual Report on Form 10-K of the Company for the year ended December 31, 2009 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
 
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
     
Dated: April 2, 2010
  /s/ SHYAM K. KUMARIA
   
    Shyam K. Kumaria
Vice President, Finance
 
 
This certification accompanies this Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.